Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria
- PMID: 34496887
- PMCID: PMC8425058
- DOI: 10.1186/s12958-021-00826-w
Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria
Erratum in
-
Correction to: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria.Reprod Biol Endocrinol. 2021 Nov 18;19(1):169. doi: 10.1186/s12958-021-00849-3. Reprod Biol Endocrinol. 2021. PMID: 34789278 Free PMC article. No abstract available.
Abstract
Background: Poor ovarian response (POR) is among the common findings in infertile women with no significant underlying condition. The aim of this study was to investigate the intra-ovarian potential of platelet-rich plasma (PRP) administration on oocytes-dependent variables in the POR women grouped according to the POSEIDON criteria.
Methods: This retrospective study was performed on POR women with no underlying condition who have undergone intra-ovarian PRP injection. As well as patients' age, the number of total and MI, MII, and GV oocytes were extracted from the files. The laboratory variables including anti-mullerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol were also gathered. In order to reduce any bias due to the possible differences in kits or devices, a single laboratory with the highest number of cases was selected and others were excluded from the study. Then, the included cases were grouped into four according to the POSEIDON criteria and analyzed for the mentioned variables by SPSS, version 25. The statistical significance level was set as P-value < 0.05.
Results: From 383 cases, a total number of 96 women were enrolled in this study. According to the POSEIDON criteria, group 4 (Age ≥ 35 years, AMH < 1.2 ng/mL) with the ratio of 56/96 (58.3%) had the highest prevalence among others. As the analyses showed, changes in the laboratory variables (LH, FSH, AMH, and estradiol) were not significant in almost all the groups following the intervention. Regarding the total oocytes number, PRP administration caused a significant increase in the total number in all the groups (all P < 0.05). Also, the number of MII oocytes was significantly increased following the treatment in all groups except for group 2 (Age ≥ 35 years, AMH ≥ 1.2 ng/mL; all P < 0.05). Of 96 cases, 14 (14.6%) got clinically pregnant following assisted reproductive techniques which this number were significantly differed among the groups (P = 0.002).
Conclusion: This study showed that PRP treatment was effective on total and MII oocyte numbers in the patients with POR, however, further studies are required.
Keywords: Female infertility; POSEIDON criteria; Platelet-rich plasma; Poor ovarian response.
© 2021. The Author(s).
Conflict of interest statement
Authors declare no actual or potential conflict of interests related to this study.
Similar articles
-
The effect of ovarian response parameters and the synergistic effect of assisted reproduction of poor ovarian response treated with platelet rich plasma: systematic review and meta-analysis.BMC Womens Health. 2024 Apr 27;24(1):263. doi: 10.1186/s12905-024-03101-3. BMC Womens Health. 2024. PMID: 38678276 Free PMC article.
-
Relationship Between Anti-Müllerian Hormone and In Vitro Fertilization-Embryo Transfer in Clinical Pregnancy.Front Endocrinol (Lausanne). 2020 Dec 4;11:595448. doi: 10.3389/fendo.2020.595448. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33343511 Free PMC article.
-
Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial.Hum Reprod. 2024 Apr 3;39(4):760-769. doi: 10.1093/humrep/deae038. Hum Reprod. 2024. PMID: 38423539 Clinical Trial.
-
Comparative efficacy of single vs. double autologous platelet-rich plasma ovarian injections for improving ovarian response in poor ovarian responders.Sci Rep. 2025 May 26;15(1):18292. doi: 10.1038/s41598-025-02689-2. Sci Rep. 2025. PMID: 40419615 Free PMC article.
-
The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2023 Dec 12;14:1292168. doi: 10.3389/fendo.2023.1292168. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38155954 Free PMC article.
Cited by
-
Evaluation of intraovarian injection of platelet-rich plasma for enhanced ovarian function and reproductive success in women with POI and POR: a systematic review and meta-analysis.Eur J Med Res. 2025 Jul 10;30(1):610. doi: 10.1186/s40001-025-02854-3. Eur J Med Res. 2025. PMID: 40640939 Free PMC article.
-
Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Jun;309(6):2323-2338. doi: 10.1007/s00404-024-07442-0. Epub 2024 Apr 8. Arch Gynecol Obstet. 2024. PMID: 38589612
-
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency.Biomolecules. 2024 Feb 19;14(2):242. doi: 10.3390/biom14020242. Biomolecules. 2024. PMID: 38397479 Free PMC article. Review.
-
One Side Ovarian Rejuvenation: A Quasi-Experimental Study of the Effect of the Autologous Platelet Rich Plasma in Poor Ovarian Responders in IVF.Ethiop J Health Sci. 2022 Nov;32(6):1133-1140. doi: 10.4314/ejhs.v32i6.10. Ethiop J Health Sci. 2022. PMID: 36475267 Free PMC article.
-
Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP).Aging (Albany NY). 2022 Mar 22;14(6):2513-2523. doi: 10.18632/aging.203972. Epub 2022 Mar 22. Aging (Albany NY). 2022. PMID: 35320118 Free PMC article.
References
-
- Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105:1452–1453. doi: 10.1016/j.fertnstert.2016.02.005. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials